itolizumab
·Code: EQ001
itolizumab: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Equillium, Inc. (EQ) | Phase 3 |
Clinical Trials (1)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Itolizumab in Combination With Corticosteroids for the Initial Treatment of Acute Graft Versus Host Disease
Frequently asked questions
Who is developing itolizumab?
itolizumab is being developed by Equillium, Inc..
How many clinical trials involve itolizumab?
BioSniper tracks 1 clinical trial involving itolizumab.
Get deeper analysis on itolizumab
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis